[3] [14] The FDA has approved several GLP-1 receptor agonists for clinical use, each with distinct characteristics regarding formulation, dosing frequency, and approved indications
Collectively, these modifications prolong the half-life of Tirzepatide to approximately 5 days (FDA package insert)
The transition from active weight loss to maintenance requires a strategic approach to dosing, ongoing medical supervision, and an understanding of how to change your lifestyle to sustain results long-term
After significant weight loss, the skin that once stretched to accommodate fullness may not contract fully
Gastrointestinal side effects like mild nausea, occasional bloating, or changes in bowel habits are common but usually manageable
$89/month is the base membership fee